Navigation Links
QMed, Inc. Receives NASDAQ Delisting Letter
Date:4/18/2008

taff's determination to the Panel, the Company's securities will not be immediately eligible to trade on the OTC Bulletin Board or in the "Pink Sheets." The securities may become eligible if a market maker makes application to register in and quote the security in accordance with SEC Rule 15c2-11, and such application (a "Form 211") is cleared. Only a market maker, not the Company, may file a Form 211. Pursuant to Marketplace Rules 6530 and 6540, a form 211 cannot be cleared if the issuer is not current in its filing obligations.

Jane Murray, QMed's president and CEO, said, "We have requested a hearing before a Nasdaq Listing Qualifications Panel to review the Staff determination of non-compliance in regard to our recent financing."

Marketplace Rule 4815 prohibits communications relevant to the merits of a proceeding under the Marketplace rule 4800 Series between the Company and the Hearings Department unless Staff is provided notice and an opportunity to participate. In that regard, Staff waived its right to participate in any oral communications between the Company and the Hearings Department. Should Staff determine to revoke such waiver, the Company will be immediately notified, and the requirements of Marketplace Rule 4815 will be strictly enforced.

The NASDAQ letter also noted, as previously disclosed in our press releases, that on December 18th, 2007, Staff notified the Company that the bid price of its common stock had closed at less than $1.00 per share over the previous 30 consecutive business days, and, as a result, did not comply with Marketplace Rule 4310(c)(4). Therefore, in accordance with Marketplace Rule 4310(c)(8)(D), the Company was provided 180 calendar days, or until June 16th, 2008, to regain compliance.

About QMed, Inc.

QMed has developed evidence-based clinical information management systems for use by health plan customers. The QMed systems incorporate Disease Management services to patients and decision sup
'/>"/>

SOURCE QMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. QMed, Inc. Reports Year-End and Fourth Quarter Results
2. QMed, Inc. Announces $750,000 in Financing and Settlement with DAKOTACARE
3. QMed, Inc. Announces the Termination of Its New Jersey Special Needs Plan
4. QMed, Inc. Receives NASDAQ Letter
5. QMed, Inc. Retains Lazard Middle Market
6. QMed, Inc. Reports Third Quarter Results
7. QMed, Inc. Extends Agreement & Receives $550,000 Performance Bonus
8. QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million
9. Ezra Susser, MD, DrPH, receives Distinguished Investigator Award from NARSAD
10. Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers Compensation Board
11. Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... For some people, tattoos are works of art that ... their lives, as they have spent a great deal of ... amount of thought on their designs. For others, however, tattoos ... simply want them removed for personal or professional reasons. In ... 2012-13 there was a 43 percent increase in the number ...
(Date:4/18/2015)... has released a new blog post explaining why ... , Spring can be a great season for purchasing ... compare the newest policies before deciding on a plan ... car insurance offers by reading the newly released blog ... and more popular. Many insurance brokerage websites like ...
(Date:4/18/2015)... Review of Ophthalmology magazine and Abbot ... Success’ program for cataract surgeons attending the American Society ... where eye surgeon Jeffrey L. Martin, MD will serve ... Martin is the Managing Partner of North Shore Eye ... Martin to lead this year’s discussion on the latest ...
(Date:4/18/2015)... 2015 Patients who undergo radiation for ... later in life, but the disease is likely to ... unrelated to radiation. Surviving Mesothelioma has just posted the ... Click here to read it now. , Scientists ... of 45 patients who had both a hematologic cancer ...
(Date:4/18/2015)... On April 14th, 2015, Symantec released ... they say, “exposes a tactical shift by cyberattackers.” With everything ... introduced in 2014 - almost a million a day - ... be identified and patched by prominent manufacturers – as long ... business in a digital world can be fraught with peril, ...
Breaking Medicine News(10 mins):Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5
... first of its kind, designed to measure the safety ... deficit/hyperactivity disorder// (ADHD) with methylphenidate (Ritalin), has revealed that ... cause harm. The study also revealed that it is ... sensitive than older children to the side effects of ...
... explained the recent improvements in the treatment of amyotrophic lateral ... paralysis. It is observed that people with the disease die ... actually stop working. Despite all the claims, cure for ALS ... disease. ,During the study, human fetal stem cells ...
... crumbling under the mounting pressure of dengue. Safdarjung Hospital ... patients being referred to AIIMS and the Red Cross. ... are given platelets only on the condition of their ... for the required platelets. Dr Santosh at the Dengue ...
... has confirmed that herceptin, a drug used for treating ... criticism// over the decision. The deputy medical director of ... expensive and funding could not be justified. The recommendation ... arrived at after complete investigation of the evidence. ...
... some valuable information which would definitely help us to ... an autistic person is blue printed. ,One ... by autism a developmental disorder typically characterized by exhibiting ... ,Lead researcher Dr Michael Murias, from the University of ...
... closet, as a virulent breast cancer strain that can be ... Among the many types of breast cancer, HER2, an aggressive ... 5 women. , ,HER2, which represents the human epidermal ... particular gene that takes care of cell growth, division and ...
Cached Medicine News:Health News:Reduced Doses of Medication Beneficial to Preschoolers with ADHD 2Health News:Reduced Doses of Medication Beneficial to Preschoolers with ADHD 3Health News:Mounting Pressure of Dengue in Delhi Hospitals 2
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/7qs3dw/corporate ... Reputation of Pharma in 2014 - a Perspective of ... their offering. This independent study, funded by ... with an interest in diabetes on the corporate reputation ... industry as a whole) in 2014. The results from ...
(Date:4/17/2015)... April 17, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), ... of innovative therapeutics for the treatment of cancer and ... presentation of data from three of its most advanced ... Research (AACR) 106 th Annual Meeting being held ... USA. The presentation on ...
(Date:4/16/2015)... , April 16, 2015  Hologic, Inc. (NASDAQ: ... cancer screening study i published on-line this ... journal of the American Cancer Society. ... the University of Pittsburgh Medical Center, supports current consensus guidelines ... that women 30-65 years of age be co-tested ...
Breaking Medicine Technology:Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4
... Clinical studies show Treximet provided significantly more patients ... relief compared to sumatriptan 85 mg, LONDON, April 15 ... (Nasdaq: POZN ) announced today that the FDA has,approved ... aura in adults. Treximet is the first and only migraine ...
... Summary: Genmab has,announced that HuMax-EGFr (zalutumumab) ... epidermal growth factor receptor (EGFr),molecules into a ... EGFr is central to its role in ... effective inhibition of cancer cell growth., ...
Cached Medicine Technology:Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 2Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 3Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 4Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 5Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 6Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 7Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS 2Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS 3
... Insert the card and turn on the Intensity ... after the programmed time. The Smart Card records ... provide your patient with the appropriate card and ... next visit.,The initial set of programmes covers treatments ...
... cutting edge High Dose Rate (HDR) treatment ... HDR 200 Sandwich. Using the Template, ... Then detach the Template, suture the Sandwich ... to secure the needles in place for ...
... templates for brachytherapy provide ... cost-effective solution. These templates ... faces to match existing ... Medical, Siemens, etc.) for ...
A sterile, cost-effective solution to eliminating the risk of cross-contamination....
Medicine Products: